Auris Medical Holding AG Presents Update On AM-111

Posted on

On January 4th 2018, Auris Medical Holding AG (ticker symbol: EARS) provided an update on AM-111 for the treatment of sudden sensorineural hearing loss. The approximately 50-minute presentation and Q&A-session were preceded by a press release by Auris Medical on the same day, and combined, the two updates contributed further knowledge on post-hoc analysis subpopulation […]